Weiang Yan

1.0k total citations
35 papers, 817 citations indexed

About

Weiang Yan is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Materials Chemistry. According to data from OpenAlex, Weiang Yan has authored 35 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Cardiology and Cardiovascular Medicine and 12 papers in Materials Chemistry. Recurrent topics in Weiang Yan's work include MXene and MAX Phase Materials (11 papers), Graphene and Nanomaterials Applications (8 papers) and Mesenchymal stem cell research (7 papers). Weiang Yan is often cited by papers focused on MXene and MAX Phase Materials (11 papers), Graphene and Nanomaterials Applications (8 papers) and Mesenchymal stem cell research (7 papers). Weiang Yan collaborates with scholars based in Canada, United States and India. Weiang Yan's co-authors include Sanjiv Dhingra, Alireza Rafieerad, Glen Lester Sequiera, Niketa Sareen, Ahmad Amiri, Ejlal Abu‐El‐Rub, Keshav Narayan Alagarsamy, Meenal Moudgil, Rakesh C. Arora and Abhay Srivastava and has published in prestigious journals such as Circulation, Advanced Functional Materials and The FASEB Journal.

In The Last Decade

Weiang Yan

31 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiang Yan Canada 15 465 346 193 146 120 35 817
Glen Lester Sequiera Canada 14 312 0.7× 267 0.8× 354 1.8× 173 1.2× 93 0.8× 31 869
Zhenqing Li China 13 208 0.4× 276 0.8× 66 0.3× 169 1.2× 125 1.0× 31 703
Subeom Park South Korea 15 440 0.9× 779 2.3× 87 0.5× 185 1.3× 116 1.0× 20 1.0k
Qinglu Li China 14 99 0.2× 117 0.3× 151 0.8× 131 0.9× 140 1.2× 51 560
Zequn Wang China 13 446 1.0× 183 0.5× 118 0.6× 37 0.3× 144 1.2× 36 864
Sachin J. Shenoy India 16 156 0.3× 355 1.0× 106 0.5× 143 1.0× 20 0.2× 45 689
Ashkan Shafiee United States 15 133 0.3× 551 1.6× 130 0.7× 134 0.9× 153 1.3× 28 880
Yaxin Hu China 17 348 0.7× 806 2.3× 118 0.6× 51 0.3× 35 0.3× 40 1.0k
Lie Wu China 15 511 1.1× 478 1.4× 233 1.2× 24 0.2× 138 1.1× 29 950

Countries citing papers authored by Weiang Yan

Since Specialization
Citations

This map shows the geographic impact of Weiang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiang Yan more than expected).

Fields of papers citing papers by Weiang Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiang Yan. The network helps show where Weiang Yan may publish in the future.

Co-authorship network of co-authors of Weiang Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Weiang Yan. A scholar is included among the top collaborators of Weiang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiang Yan. Weiang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Weiang, Keshav Narayan Alagarsamy, Abhay Srivastava, et al.. (2025). Rosuvastatin-loaded injectable immunomodulatory hydrogel mitigates local immune response against transplanted stem cells and promotes heart repair in vivo. Biomaterials Advances. 178. 214481–214481.
2.
Sareen, Niketa, et al.. (2024). Reduced cyclooxygenase 2 levels after hypoxia exposure result in the loss of immunoprivilege of allogeneic mesenchymal stem cells. Vascular Pharmacology. 155. 107351–107351. 1 indexed citations
3.
Sequiera, Glen Lester, Abhay Srivastava, Niketa Sareen, et al.. (2022). Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases. Science Advances. 8(14). eabl4370–eabl4370. 17 indexed citations
4.
Yan, Weiang, et al.. (2022). Long-term survival and quality of life after extracorporeal membrane oxygenation. Journal of Thoracic and Cardiovascular Surgery. 166(2). 555–566.e2. 13 indexed citations
5.
Yan, Weiang, et al.. (2022). A previously undescribed pathogenic variant in FBN1 gene causing Marfan syndrome: a case report. European Heart Journal - Case Reports. 6(3). ytac063–ytac063. 1 indexed citations
6.
Yan, Weiang, et al.. (2022). Immunoengineered MXene nanosystem for mitigation of alloantigen presentation and prevention of transplant vasculopathy. Nano Today. 48. 101706–101706. 25 indexed citations
7.
Alagarsamy, Keshav Narayan, et al.. (2021). Carbon nanomaterials for cardiovascular theranostics: Promises and challenges. Bioactive Materials. 6(8). 2261–2280. 57 indexed citations
8.
Rafieerad, Alireza, Weiang Yan, Keshav Narayan Alagarsamy, et al.. (2021). Fabrication of Smart Tantalum Carbide MXene Quantum Dots with Intrinsic Immunomodulatory Properties for Treatment of Allograft Vasculopathy (Adv. Funct. Mater. 46/2021). Advanced Functional Materials. 31(46). 1 indexed citations
9.
Franchi, Federico, et al.. (2020). Abstract 16757: Immunomodulatory Hydrogel Promotes Survival of Mesenchymal Stem Cells in a Rat Model of Myocardial Infarction. Circulation. 142(Suppl_3). 2 indexed citations
10.
Sareen, Niketa, Ejlal Abu‐El‐Rub, Hania Ibrahim Ammar, et al.. (2020). Hypoxia‐induced downregulation of cyclooxygenase 2 leads to the loss of immunoprivilege of allogeneic mesenchymal stem cells. The FASEB Journal. 34(11). 15236–15251. 12 indexed citations
11.
Abu‐El‐Rub, Ejlal, Niketa Sareen, Weiang Yan, et al.. (2020). Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells. Cell Death and Disease. 11(6). 419–419. 14 indexed citations
12.
Lodewyks, Carly, et al.. (2020). The COMPASS trial: practical considerations for application after coronary artery bypass surgery. Current Opinion in Cardiology. 35(5). 583–588. 2 indexed citations
13.
Abu‐El‐Rub, Ejlal, Glen Lester Sequiera, Niketa Sareen, et al.. (2019). Hypoxia-induced 26S proteasome dysfunction increases immunogenicity of mesenchymal stem cells. Cell Death and Disease. 10(2). 90–90. 29 indexed citations
14.
Rafieerad, Alireza, et al.. (2019). Sweet-MXene hydrogel with mixed-dimensional components for biomedical applications. Journal of the mechanical behavior of biomedical materials. 101. 103440–103440. 54 indexed citations
15.
16.
Alagarsamy, Keshav Narayan, Weiang Yan, Abhay Srivastava, Vincenzo Desiderio, & Sanjiv Dhingra. (2019). Application of injectable hydrogels for cardiac stem cell therapy and tissue engineering. Reviews in Cardiovascular Medicine. 20(4). 221–230. 26 indexed citations
17.
Rafieerad, Alireza, Weiang Yan, Glen Lester Sequiera, et al.. (2019). Application of Ti3C2 MXene Quantum Dots for Immunomodulation and Regenerative Medicine. Advanced Healthcare Materials. 8(16). e1900569–e1900569. 161 indexed citations
18.
Yan, Weiang, et al.. (2018). Multimodality Imaging of a Giant Right Coronary Artery Aneurysm. Canadian Journal of Cardiology. 34(12). 1688.e5–1688.e7. 2 indexed citations
19.
Yan, Weiang, et al.. (2017). Extracorporeal membrane oxygenation before surgical repair of a postinfarction ventricular septal defect. Journal of Thoracic and Cardiovascular Surgery. 155(4). e121–e123. 4 indexed citations
20.
Cutter, Asher D., et al.. (2010). Molecular population genetics and phenotypic sensitivity to ethanol for a globally diverse sample of the nematodeCaenorhabditis briggsae. Molecular Ecology. 19(4). 798–809. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glen Lester Sequiera Breakdown of academic impact, for papers by Zhenqing Li Breakdown of academic impact, for papers by Subeom Park Breakdown of academic impact, for papers by Qinglu Li Breakdown of academic impact, for papers by Zequn Wang Breakdown of academic impact, for papers by Sachin J. Shenoy Breakdown of academic impact, for papers by Ashkan Shafiee Breakdown of academic impact, for papers by Yaxin Hu Breakdown of academic impact, for papers by Lie Wu
Rankless by CCL
2026